| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/04/1994 | EP0594881A1 Expression vectors and their application in the construction of HIV-resistant human cells for therapeutic uses |
| 05/04/1994 | EP0594669A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | WO1994009137A1 Antibodies against type 2 tumor necrosis factor receptor |
| 04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
| 04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | WO1994009119A1 Remyelination using neural stem cells |
| 04/28/1994 | WO1994009118A1 Immortalized human chondrocytes |
| 04/28/1994 | WO1994008625A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | WO1994008606A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/28/1994 | WO1994008598A1 Liver reserve cells |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | CA2147663A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | CA2147127A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | CA2146766A1 Polypeptides with a serotoninergic receptor activity (5ht2c) and uses therefor |
| 04/28/1994 | CA2145863A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/27/1994 | EP0593901A2 Oligoribonucleotide- and ribozyme-analoguer with terminal 3',3'- and 5',5'-bonds respectively |
| 04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 04/27/1994 | EP0593663A1 Method and assay system for neurotrophin activity |
| 04/26/1994 | US5306508 Red blood cell surrogate |
| 04/20/1994 | EP0592836A1 Human adeno-associated virus integration site DNA and uses thereof |
| 04/20/1994 | EP0592634A1 Inhibitor of protein kinase c |
| 04/19/1994 | US5304489 DNA sequences to target proteins to the mammary gland for efficient secretion |
| 04/19/1994 | US5304121 Catheter |
| 04/14/1994 | WO1994008026A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 04/14/1994 | WO1994008022A1 Vector to deliver and express foreign gene |
| 04/14/1994 | WO1994008008A1 Improvements in or relating to immune response modification |
| 04/14/1994 | WO1994008004A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 04/14/1994 | WO1994008002A2 Methods and compositions for controlling translation of hcv proteins |
| 04/14/1994 | WO1994007522A1 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | CA2146364A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 04/13/1994 | EP0591462A1 Universal donor cells |
| 04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0376968B1 Chromosome-specific nucleic acid probe for familial polyposis coli |
| 04/12/1994 | US5302706 Senescent cell derived inhibitors of DNA synthesis |
| 04/06/1994 | EP0590132A1 $i(IN VITRO)-DERIVED HUMAN NEUTROPHIL PRECURSOR CELLS |
| 04/06/1994 | EP0590090A1 SELECTIVE INHIBITION OF LEUKEMIC CELL PROLIFERATION BY $i(BCR-ABL) ANTISENSE OLIGONUCLEOTIDES |
| 04/06/1994 | EP0590082A1 Antisense oligonucleotide inhibition of the ras gene |
| 04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
| 03/31/1994 | WO1994006922A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell |
| 03/31/1994 | WO1994006920A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | WO1994006916A1 Gene transcription and ionizing radiation: methods and compositions |
| 03/31/1994 | WO1994006910A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | WO1994006813A1 Major histocompatibility complex molecules and modifications thereof |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994006449A2 Morphogen-induced liver regeneration |
| 03/31/1994 | WO1994006447A2 60a protein-induced morphogenesis |
| 03/31/1994 | WO1994006420A2 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | WO1994006399A1 Morphogen-induced periodontal tissue regeneration |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | CA2145063A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | CA2144848A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | CA2144659A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell |
| 03/31/1994 | CA2144515A1 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
| 03/30/1994 | EP0589330A2 NF-kappa beta antisense polynucleotides |
| 03/30/1994 | EP0588914A1 Eukaryotic expression vectors with regulation of rna processing |
| 03/30/1994 | EP0588881A1 3'-end blocked oligonucleotides |
| 03/30/1994 | CN1084564A Antisense polynucleotides |
| 03/29/1994 | US5298422 Myogenic vector systems |
| 03/24/1994 | CA2105595A1 Antisense polynucleotides |
| 03/23/1994 | EP0587771A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
| 03/23/1994 | EP0587738A1 Targeted delivery of genes encoding secretory proteins |
| 03/18/1994 | CA2106260A1 Human adeno-associated virus integration site dna and uses thereof |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005782A1 In vivo production of transgenic organ by introducing the transgene via lumen |
| 03/17/1994 | WO1994005691A1 Cd27 ligand |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005315A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | WO1994005313A1 Treatment of gynecological malignancies with biologically active peptides |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2141935A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/09/1994 | EP0585983A2 Nucleotide vector comprising a translation inhibition factor gene, and IRES region and a desired gene |
| 03/09/1994 | EP0585415A1 Dna encoding a human 5-ht 1e? receptor and uses thereof |
| 03/09/1994 | EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/03/1994 | WO1994004695A1 Herpesviral defective vector with rat preproenkephalin gene promoter |
| 03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
| 03/03/1994 | WO1994004683A1 Bordetella bronchiseptica vaccine |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |